BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23987798)

  • 21. Genetic effect of CCR3 and IL5RA gene polymorphisms on eosinophilia in asthmatic patients.
    Lee JH; Chang HS; Kim JH; Park SM; Lee YM; Uh ST; Rhim T; Chung IY; Kim YH; Park BL; Park CS; Shin HD
    J Allergy Clin Immunol; 2007 Nov; 120(5):1110-7. PubMed ID: 17983872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.
    Carruthers MN; Park S; Slack GW; Dalal BI; Skinnider BF; Schaeffer DF; Dutz JP; Law JK; Donnellan F; Marquez V; Seidman M; Wong PC; Mattman A; Chen LY
    Eur J Haematol; 2017 Apr; 98(4):378-387. PubMed ID: 28005278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome.
    Helbig G; Wieczorkiewicz A; Dziaczkowska-Suszek J; Majewski M; Kyrcz-Krzemien S
    Haematologica; 2009 Sep; 94(9):1236-41. PubMed ID: 19734416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
    Lampinen M; Oberg G; Venge P; Carlson M
    APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome.
    Satoh T; Sun L; Li MS; Spry CJ
    Immunology; 1994 Oct; 83(2):308-12. PubMed ID: 7835952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.
    Ochiai K; Iwamoto I; Takahashi H; Yoshida S; Nakagawa N; Tomioka H; Yoshida S
    Clin Exp Immunol; 1991 May; 84(2):283-8. PubMed ID: 2025954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD3
    Carpentier C; Schandené L; Dewispelaere L; Heimann P; Cogan E; Roufosse F
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2426-2439.e7. PubMed ID: 33545400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
    Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
    Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics.
    Kuang FL; Curtin BF; Alao H; Piligian B; Berry A; Holland-Thomas N; Powers A; Quezado M; Lumbard K; Fay MP; Klion AD; Kumar S; Khoury P
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2718-2726.e2. PubMed ID: 32344186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review.
    Chapuis E; Bousquet E; Viallard JF; Terrier B; Amoura Z; Batani V; Brézin A; Cacoub P; Caminati M; Chazal T; Comarmond C; Durieu I; Ebbo M; Grall M; Ledoult E; Losappio L; Mattioli I; Mékinian A; Padoan R; Regola F; Schroeder J; Seluk L; Trefond L; Wechsler ME; Lefevre G; Kahn JE; Sève P; Groh M
    Front Immunol; 2024; 15():1379611. PubMed ID: 38720897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects.
    Bozza PT; Yu W; Cassara J; Weller PF
    J Leukoc Biol; 1998 Oct; 64(4):563-9. PubMed ID: 9766638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.
    Helbig G; Moskwa A; Hus M; Piszcz J; Swiderska A; Urbanowicz A; Całbecka M; Gajkowska J; Seferyńska I; Hałasz M; Woszczyk D; Markiewicz M; Krzemień S
    Hematol Oncol; 2010 Jun; 28(2):93-7. PubMed ID: 19728396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil.
    Hanbali A; Shaheen M; Alfraih F; Al-Otaibi W; El Fakih R; Owaidah T; Ahmed S
    Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):241-244. PubMed ID: 28174010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome.
    de Lavareille A; Roufosse F; Schmid-Grendelmeier P; Roumier AS; Schandené L; Cogan E; Simon HU; Goldman M
    J Allergy Clin Immunol; 2002 Sep; 110(3):476-9. PubMed ID: 12209097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia-associated diseases.
    Kobayashi S; Inokuma S; Setoguchi K; Kono H; Abe K
    Allergy; 2002 Oct; 57(10):950-6. PubMed ID: 12269945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood and Bone Marrow Evaluation for Eosinophilia.
    Boyer DF
    Arch Pathol Lab Med; 2016 Oct; 140(10):1060-7. PubMed ID: 27684977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
    Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.
    Bobbio-Pallavicini E; Confalonieri M; Tacconi F; Mainardi E; Della Porta R; Ceccato D; Maccario R; De Amici M
    Panminerva Med; 1998 Sep; 40(3):186-90. PubMed ID: 9785914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.